Auditor casts doubt over Pharmaniaga


KUALA LUMPUR: Pharmaniaga Bhd’s independent auditor has issued a material uncertainty that may cast significant doubt on the group’s ability to continue as a going concern in respect of the group’s financial statements for the financial year ended Dec 31, 2023 (FY23).

In its report on March 29, 2024, the independent auditor Messrs PricewaterhouseCoopers PLT indicated that the group and company incurred net losses of RM78.7mil and RM63.3mil, respectively, in FY23.

As at Dec 31, 2023, the group and company’s current liabilities exceeded their current assets by RM895mil and RM439mil, respectively, and recorded a capital deficiency of RM274.1mil.

As stated in Note 2 in the financial statements, these events or conditions indicate that a material uncertainty exists that may cast significant doubt on the group and company’s ability to continue as a going concern.

“Our opinion is not modified in respect of this matter,” the auditor noted. — Bernama

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Malaysia’s capital market hits RM4 trillion milestone, driven by strong domestic growth and IPO surge
TopVision makes ACE Market debut with 18% premium
China November industrial output rises 5.4%, above expectations
Foreign investors extend Bursa Malaysia sell-off with RM882.4mil outflow
Bitcoin surges above US$106,000 on strategic reserve hopes
Ringgit up marginally against US dollar in early trade
FBM KLCI inches up in early trade; TopVision shines in debut
Trading ideas: Axiata, Yinson, Datasonic, Exsim Hospitality, Lotte Chemical Titan, T7
Experts see big expansionary moves ahead by China’s government
MicroStrategy, Palantir added to Nasdaq 100, with Moderna facing an exit

Others Also Read